APAC to emerge as key player in the global AI oncology market | Healthcare Asia Magazine
, APAC
Photo from Envato

APAC to emerge as key player in the global AI oncology market

Its growth is fuelled by rapid technological advancements and increased healthcare investments.

The Asia Pacific (APAC) region is poised to emerge as a key player in the global AI oncology market, which is projected to reach $7.7b in sales revenue by the end of 2034, according to Transparency Market Research.

The region’s growth is attributed to rapid technological advancements and increased healthcare investments.

Countries such as China, Japan, and South Korea are investing in AI-based diagnostics and treatment to address the rising burden of cancer.

Moreover, collaborations between technology firms, healthcare organisations, and government agencies are further driving the APAC landscape.

Overall, the demand for accurate diagnosis and personalised treatment is propelling the use of AI in the field of oncology.

 

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!